U.S. risks prolonging pandemic if it doesn’t back WTO push to get vaccines and treatments to lower-income countries, lawmakers warn
admin The U.S. is at risk of prolonging the COVID pandemic if it fails to back…
Read Moremedications
U.S. risks prolonging pandemic if it doesn’t back WTO push to get vaccines and treatments to lower-income countries, lawmakers warn
The U.S. is at risk of prolonging the COVID pandemic if it fails to back…
Read MoreWhy aren’t new drugs that can help you lose weight more widely used?
A pair of new drugs offer something many Americans desperately want: a way to lose…
Read MoreHere’s one thing that will cost less next year—what it means for Medicare beneficiaries
This article is reprinted by permission from NerdWallet. While inflation is pushing up prices for…
Read MoreGetting Medicare to cover Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
An experimental Alzheimer’s disease treatment developed by Eisai and Biogen that appears to slow cognitive…
Read MoreRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreEisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreAlzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read More
Opinion: The opioid epidemic is costing us $1.5 trillion a year. And we’re spending peanuts to fight it.
The U.S. economy is being battered on all sides: Inflation, snarled supply chains, severe labor…
Read More